Yanping Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry 67 (16) (2024)
Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry 67 (16) (2024)
Guiqun Yang, Yiwei Lin, Xin Sun, Dai Cheng, Haijun Li, Shizong Hu, Mingming Chen, Yinxiang Wang, Yanping Wang
Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties. ACS omega 9 (19) (2024)
Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry (2024)
Guiqun Yang, Yiwei Lin, Xin Sun, Dai Cheng, Haijun Li, Shizong Hu, Mingming Chen, Yinxiang Wang, Yanping Wang
Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties. ACS omega 9 (19) (2024)